May 13, 2022
Via: ScienceDailyIn early research led by the University of Michigan Health Rogel Cancer Center, the oral medication zanubrutinib was found to help most patients with a slow-growing type of cancer known as marginal zone lymphoma. Cancers shrunk in 80% of the […]
December 11, 2020
Via: MedPageTodayTreatment-free remission is now regarded as a primary aim of patients with long-term chronic myeloid leukemia (CML). Starting with the approval of imatinib in 2001, the effectiveness of tyrosine kinase inhibitors (TKIs) has resulted in significant improvements in outcomes for […]
October 4, 2018
Via: The Medical NewsNew research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD) in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the […]
July 17, 2024
Copyright © 2024. All rights reserved
